نتایج جستجو برای: cyp3a4 promoter

تعداد نتایج: 92660  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2000
T Naoe K Takeyama T Yokozawa H Kiyoi M Seto N Uike T Ino A Utsunomiya A Maruta I Jin-nai N Kamada Y Kubota H Nakamura C Shimazaki S Horiike Y Kodera H Saito R Ueda J Wiemels R Ohno

Several genetic polymorphisms in metabolic activation or detoxification enzymes have been associated with susceptibility to therapy-related leukemia and myelodysplastic leukemia (TRLIMDS). We analyzed gene polymorphisms of NAD(P)H:quinone oxidoreductase (NQOl), glutathione S-tranferase (GST)-MI and -TI, and CYP3A4, the enzymes of which are capable of metabolizing anticancer drugs, in 58 patient...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2002
Celeste Lindley Geraldine Hamilton Jeannine S McCune Stephanie Faucette Stacy S Shord Roy L Hawke Hongbing Wang Darryl Gilbert Summer Jolley Bingfang Yan Edward L LeCluyse

The purpose of this study was to characterize the concentration-response effects of cyclophosphamide (CPA) with and without dexamethasone (DEX; 10 microM) on the expression of CYP3A4 and CYP2B6 in cultured human hepatocytes at concentrations representative of standard- and high-dose CPA therapy (25 to 750 microM). CPA produced concentration-dependent increases in CYP3A4 and CYP2B6 activity and ...

2015
Christian S. Müller Tim Knehans Dmitri R. Davydov Patricia L. Bounds Ursula von Mandach James R. Halpert Amedeo Caflisch Willem H. Koppenol

Cytochrome P450 3A4 (CYP3A4) is the major human P450 responsible for the metabolism of carbamazepine (CBZ). To explore the mechanisms of interactions of CYP3A4 with this anticonvulsive drug, we carried out multiple molecular dynamics (MD) simulations, starting with the complex of CYP3A4 manually docked with CBZ. On the basis of these simulations, we engineered CYP3A4 mutants I369F, I369L, A370V...

Journal: :The Journal of pharmacology and experimental therapeutics 2012
Linhao Li Michael W Sinz Kurt Zimmermann Hongbing Wang

Inhibition of insulin-like growth factor-1 receptor (IGF-1R) signaling represents an attractive therapeutic strategy for cancer treatment. A first-generation IGF-1R inhibitor (R)-4-(3-(3-chlorophenyl)-3-hydroxypropyl)-3-(4-methyl-6-morpholino-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one (BMS-536924), however, was associated with potent CYP3A4 induction mediated by pregnane X receptor (PXR; NR1I2)...

2013
Linda Björkhem-Bergman Tobias Bäckström Hanna Nylén Yuko Rönquist-Nii Eva Bredberg Tommy B. Andersson Leif Bertilsson Ulf Diczfalusy

CYP3A4, considered the most important enzyme in drug metabolism, is often involved in drug-drug interactions. When developing new drugs, appropriate markers for detecting CYP3A4 induction are needed. Our study compared endogenously formed 4b-hydroxycholesterol with the midazolam clearance in plasma and the 6b-hydroxycortisol/cortisol ratio in urine as markers for CYP3A4 induction. To this end, ...

Journal: :The Journal of pharmacology and experimental therapeutics 2003
Jeffrey C Stevens Ronald N Hines Chungang Gu Sevasti B Koukouritaki Jason R Manro Peter J Tandler Matthew J Zaya

The human cytochrome P4503A forms show expression patterns subject to developmental influence. CYP3A7 and CYP3A4 are generally classified as the major fetal and adult liver forms, respectively. However, characterization of CYP3A4, -3A5, and -3A7 developmental expression has historically been confounded by the lack of CYP3A isoform-specific antibodies or marker enzyme activities. Therefore, the ...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2001
T Kilicarslan R L Haining A E Rettie U Busto R F Tyndale E M Sellers

We have identified CYP2C19 and CYP3A4 as the principal cytochrome P450s involved in the metabolism of flunitrazepam to its major metabolites desmethylflunitrazepam and 3-hydroxyflunitrazepam. Human CYP2C19 and CYP3A4 mediated the formation of desmethylflunitrazepam with Km values of 11.1 and 108 microM, respectively, and 3-hydroxyflunitrazepam with Km values of 642 and 34.0 microM, respectively...

Journal: :African health sciences 2015
Liu Xiaoyang Ni Chenming Li Chengqing Liu Tao

BACKGROUND Gomisin G, isolated from herb Schisandra chinensis, exhibits anti-tumor activities. Therefore, Gomisin G is a drug candidate for anti-liver cancer therapy. AIMS To predict the metabolic behavior and metabolism-based drug-drug interaction of gomisin G. METHODS Molecular docking method was used. The crystal structure of CYP3A4 with the ligand ketoconazole was chosen from protein da...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2013
Linda Björkhem-Bergman Tobias Bäckström Hanna Nylén Yuko Rönquist-Nii Eva Bredberg Tommy B Andersson Leif Bertilsson Ulf Diczfalusy

CYP3A4, considered the most important enzyme in drug metabolism, is often involved in drug-drug interactions. When developing new drugs, appropriate markers for detecting CYP3A4 induction are needed. Our study compared endogenously formed 4β-hydroxycholesterol with the midazolam clearance in plasma and the 6β-hydroxycortisol/cortisol ratio in urine as markers for CYP3A4 induction. To this end, ...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2008
Leslie M Tompkins Tim L Sit Andrew D Wallace

The pregnane X receptor (PXR) is known as the xenosensing receptor responsible for coordinated regulation of metabolic genes in response to diverse xenobiotic challenges. In particular, the ability of the PXR to regulate CYP3A4, the enzyme capable of metabolizing more than 60% of all pharmaceuticals, defines its metabolic importance. Currently the list of PXR ligands and target genes is extensi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید